We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/10/2017 12:21 | It seems to me that whilst they've been overcoming the ambient temperature effect over the last two years, there has been a growing pent up demand and professional awareness of the need for the product which will help with the necessary approvals and commercial launch. It's an ill wind that blows no good. | columbarius | |
13/10/2017 11:04 | Lets not get ahead of ourselves Dibs, we need to complete all the field trials then apply for CE Approval before we can commercialize CD4 then we may need individual country regulation approvals before we can sell into some of them....but heading in the right direction, should be an interesting Update when it arrives...with regards Training being given at present always a good sign...imho | barrywhit | |
12/10/2017 14:56 | Let them know your holiday plans barry and they might be able to accommodate you : ) They should have something to say by now about the IDH contract. We've waited long enough. | columbarius | |
12/10/2017 12:30 | Hope we get the update before end of month as I am in India for 23 days starting 30th October.....would like to go away having read the trading update.. | barrywhit | |
12/10/2017 12:05 | I'm sure we'll soon have plenty to whoop and holler about! | longshanks | |
12/10/2017 11:09 | Very quiet the week before the Trading Update, should be next week but no guarantee I suppose...... | barrywhit | |
10/10/2017 13:38 | Looks like the confusing Holdings RNS has scared a few.......LOL | barrywhit | |
10/10/2017 08:47 | Section 9 of the RNS states: 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is X not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer(xiii) The x shows they ticked that box... | barrywhit | |
10/10/2017 08:46 | I think the forms have got worse. I'm sure they'd prefer us to read them through a beer bottle. | columbarius | |
10/10/2017 08:30 | This TR-1 form is just not fit for purpose, since it does not make clear which of the two alternatives ‘acquisition Doze (CI) | dozey3 | |
10/10/2017 08:12 | Mills does need to gee up NAS growth compared to peers though, Treasuries + Gleeson is a hell of a % of the fund in 2 holdings and its not motoring. It will do OK if shtf in the markets but until that happens it looks like a laggard. | p1nkfish | |
10/10/2017 08:10 | If I remember correctly they did sell down around the time Sneller was adding time before last. Mills has seen CRX sold, taken SBS private and handle EKF well, seeing off the ex-Alere man poking his nose in. Might just be he is looking to ODX next and trying to avoid overpaying to get back in. Doesn't explain why they declare <3% though unless as a related party totalling > 3% but no mention of that. | p1nkfish | |
10/10/2017 08:03 | See if there is a change in Harwood holdings. Mills is behind it all. | p1nkfish | |
10/10/2017 08:01 | I have been monitoring Oryx and the last time I checked they had no holding at all.My take on this RNS is that Harwood Capital and Oryx are related and so they have had to declare this as a new additional holding over and above the 5m shares owned by Harwood. If it was just Oryx then there would have been no declaration requirement as it is below 3%. Confusing though. | longshanks | |
10/10/2017 07:52 | Holdings RNS, is that a new holding as they aren't shown on the holdings over 3% previously or is that to do with Harwood? Oryx last holding RNS showed they held 3,000,000 July 2016 less then 3% So they could have increased their holding by 600,000 | barrywhit | |
07/10/2017 11:13 | Agreed guys and p1nkfish that's exactly my strategy and because I see sustained long term stronger growth why would I sell a single share? Yesterday's sells certainly baffled me too but I do feel there remains background buyer(s) who will/are snaffling them up. Long term HOLD and ADD | dibs61 | |
07/10/2017 08:23 | nowt so strange as folk p1nkfish....you will always get sellers..... | barrywhit | |
07/10/2017 00:30 | You have to ask why anyone who didn't need the money immediately would sell at this juncture. Hold firm, look to add on weakness, be patient & gla. | p1nkfish | |
06/10/2017 22:48 | Or it could be regarding the Malaria (or other) POC tests they already have CE marked ..... whatever it is it sounds very positive to me | dibs61 | |
06/10/2017 22:37 | They specifically mention POC and RDT experience. Does this mean the Visitect CD4 trials have concluded successfully and they are ready to move to commercialisation? Clearly they need CE mark first but maybe that will follow quite quickly now and they are moving a step ahead? | dibs61 | |
06/10/2017 20:59 | It is music to my ears as well becauseit feels feels like the starting pistol going off | bomber13 | |
06/10/2017 16:37 | Just taken off ODX twitter feed: Looking for #distributors across Africa. Committed to global health issues? Email odl@omegadiagnostics | hyperboreus | |
05/10/2017 19:56 | Only joking longshanks, positions being taken ready for the trading update....imo | barrywhit |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions